These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

686 related articles for article (PubMed ID: 29888987)

  • 1. Role of epigenetics in Alzheimer's disease pathogenesis.
    Stoccoro A; Coppedè F
    Neurodegener Dis Manag; 2018 Jun; 8(3):181-193. PubMed ID: 29888987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetics of Alzheimer's Disease.
    Nikolac Perkovic M; Videtic Paska A; Konjevod M; Kouter K; Svob Strac D; Nedic Erjavec G; Pivac N
    Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33573255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetics and DNA methylomic profiling in Alzheimer's disease and other neurodegenerative diseases.
    Roubroeks JAY; Smith RG; van den Hove DLA; Lunnon K
    J Neurochem; 2017 Oct; 143(2):158-170. PubMed ID: 28805248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetics in Alzheimer's Disease: Perspective of DNA Methylation.
    Qazi TJ; Quan Z; Mir A; Qing H
    Mol Neurobiol; 2018 Feb; 55(2):1026-1044. PubMed ID: 28092081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mitochondrial epigenome: a role in Alzheimer's disease?
    Devall M; Mill J; Lunnon K
    Epigenomics; 2014; 6(6):665-75. PubMed ID: 25531259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer's disease: the potential of epigenetic treatments and current clinical candidates.
    Coneys R; Wood IC
    Neurodegener Dis Manag; 2020 Jun; 10(3):543-558. PubMed ID: 32552286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic regulation of mitochondrial function in neurodegenerative disease: New insights from advances in genomic technologies.
    Devall M; Roubroeks J; Mill J; Weedon M; Lunnon K
    Neurosci Lett; 2016 Jun; 625():47-55. PubMed ID: 26876477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic mechanisms in Alzheimer's disease: implications for pathogenesis and therapy.
    Wang J; Yu JT; Tan MS; Jiang T; Tan L
    Ageing Res Rev; 2013 Sep; 12(4):1024-41. PubMed ID: 23688931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic dysregulation in Alzheimer's disease: cause or consequence?
    van den Hove DL; Kenis G; Rutten BP
    Epigenomics; 2014 Feb; 6(1):9-11. PubMed ID: 24579941
    [No Abstract]   [Full Text] [Related]  

  • 10. Epigenetics in Alzheimer's disease: a focus on DNA modifications.
    Coppieters N; Dragunow M
    Curr Pharm Des; 2011; 17(31):3398-412. PubMed ID: 21902668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging epigenetics in Alzheimer's disease.
    Lista S; Garaci FG; Toschi N; Hampel H
    Curr Pharm Des; 2013; 19(36):6393-415. PubMed ID: 23432717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenome-wide association studies in Alzheimer's disease; achievements and challenges.
    van den Hove DLA; Riemens RJM; Koulousakis P; Pishva E
    Brain Pathol; 2020 Sep; 30(5):978-983. PubMed ID: 32654262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic regulons in Alzheimer's disease.
    Raval M; Mishra S; Tiwari AK
    Prog Mol Biol Transl Sci; 2023; 198():185-247. PubMed ID: 37225321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's Disease-Related Epigenetic Changes: Novel Therapeutic Targets.
    Paniri A; Hosseini MM; Akhavan-Niaki H
    Mol Neurobiol; 2024 Mar; 61(3):1282-1317. PubMed ID: 37700216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's Disorder: Epigenetic Connection and Associated Risk Factors.
    Sharma VK; Mehta V; Singh TG
    Curr Neuropharmacol; 2020; 18(8):740-753. PubMed ID: 31989902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The epigenetic dimension of Alzheimer's disease: causal, consequence, or curiosity?
    Millan MJ
    Dialogues Clin Neurosci; 2014 Sep; 16(3):373-93. PubMed ID: 25364287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic Modifications in Neurological Diseases: Natural Products as Epigenetic Modulators a Treatment Strategy.
    Gangisetty O; Murugan S
    Adv Neurobiol; 2016; 12():1-25. PubMed ID: 27651245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetics and pharmacology.
    Stefanska B; MacEwan DJ
    Br J Pharmacol; 2015 Jun; 172(11):2701-4. PubMed ID: 25966315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenomic approach in understanding Alzheimer's disease and type 2 diabetes mellitus.
    Shaik MM; Gan SH; Kamal MA
    CNS Neurol Disord Drug Targets; 2014 Mar; 13(2):283-9. PubMed ID: 24074446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic regulation in the pathophysiology of Alzheimer's disease.
    Chouliaras L; Rutten BP; Kenis G; Peerbooms O; Visser PJ; Verhey F; van Os J; Steinbusch HW; van den Hove DL
    Prog Neurobiol; 2010 Apr; 90(4):498-510. PubMed ID: 20097254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.